Literature DB >> 30257106

MicroRNA-21 mediates high phosphate-induced endothelial cell apoptosis.

Zhaoyu Li1,2, Szymon Wiernek1, Cam Patterson1, Huanchen Wang3, Guoxian Qi2, Xuming Dai1.   

Abstract

Hyperphosphatemia, the elevated level of inorganic phosphate (Pi) in serum, is associated with increased cardiovascular morbidities and mortality. The effects of high Pi on endothelial cells are not well studied. This study investigated high Pi-induced endothelial cell apoptosis and the role of microRNA-21. Mouse myocardial endothelial cells (MEC) were cultured in normal (1 mM) and high (5 mM) Pi conditions. Apoptosis was detected by TUNEL staining and flow cytometry. MicroRNA profiles of MEC response to changes in Pi concentration were obtained using gene expression arrays. Expression levels of the microRNA-21 target genes, programmed cell death gene 4 ( PDCD4), poly(ADP-ribose) polymerase ( PARP), and phosphatase and tensin homolog ( PTEN), as well as NF-κB were measured by Western blotting and RT-PCR. MicroRNA-21-specific inhibitors and mimics were used to study effects of microRNA-21 on MEC apoptosis and gene expression regulations. High Pi induced MEC apoptosis and upregulated microRNA-21 expression. MicroRNA-21-specific mimics reproduced high Pi-induced apoptosis in normal Pi medium, and microRNA-21 inhibitors ameliorated the high Pi induction of apoptosis, suggesting that microRNA-21 mediated high Pi-induced MEC apoptosis. The microRNA-21 targets PDCD4, PTEN, PARP, and NF-κB were significantly downregulated in high Pi conditions. High Pi-induced downregulation of PDCD4 was abolished by microRNA-21 inhibitors and selective ERK inhibitor (selumetinib) and was reproduced by microRNA-21 mimics. Inhibitors and mimics of microRNA-21 did not have effects on high Pi-induced NF-κB downregulation. Selumetinib blocked high Pi-induced NF-κB downregulation. MicroRNA-21 mediates high Pi-induced endothelial cell apoptosis, which involves an ERK1/2/microRNA-21/PDCD4 pathway. High Pi-induced downregulation of NF-κB expression is mediated by an ERK1/2 signaling-dependent but microRNA-21-independent mechanism.

Entities:  

Keywords:  ERK1/2; NF-κB; PDCD4; apoptosis; endothelial cells; hyperphosphatemia; microRNA-21

Mesh:

Substances:

Year:  2018        PMID: 30257106      PMCID: PMC6336940          DOI: 10.1152/ajpcell.00198.2018

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  40 in total

1.  Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing.

Authors:  Gunter Meister; Markus Landthaler; Yair Dorsett; Thomas Tuschl
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

Review 2.  Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics.

Authors:  Jeremy L Yap; Shilpa Worlikar; Alexander D MacKerell; Paul Shapiro; Steven Fletcher
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

3.  MicroRNA-21, induced by high glucose, modulates macrophage apoptosis via programmed cell death 4.

Authors:  Yuan-Yuan Shang; Ning-Ning Fang; Feng Wang; Hui Wang; Zhi-Hao Wang; Meng-Xiong Tang; Jie Peng; Yun Zhang; Wei Zhang; Ming Zhong
Journal:  Mol Med Rep       Date:  2015-02-27       Impact factor: 2.952

4.  Phosphate regulation of vascular smooth muscle cell calcification.

Authors:  S Jono; M D McKee; C E Murry; A Shioi; Y Nishizawa; K Mori; H Morii; C M Giachelli
Journal:  Circ Res       Date:  2000-09-29       Impact factor: 17.367

5.  MicroRNA-21 negatively regulates Treg cells through a TGF-β1/Smad-independent pathway in patients with coronary heart disease.

Authors:  Sihui Li; Qian Fan; Shaolin He; Tingting Tang; Yuhua Liao; Jiangjiao Xie
Journal:  Cell Physiol Biochem       Date:  2015-09-18

6.  MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.

Authors:  Ruirui Ji; Yunhui Cheng; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Circ Res       Date:  2007-05-03       Impact factor: 17.367

7.  Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent.

Authors:  George R Beck; Nicole Knecht
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

8.  Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: possible implication of apoptosis in the regulation of endochondral ossification.

Authors:  D Magne; G Bluteau; C Faucheux; G Palmer; C Vignes-Colombeix; P Pilet; T Rouillon; J Caverzasio; P Weiss; G Daculsi; J Guicheux
Journal:  J Bone Miner Res       Date:  2003-08       Impact factor: 6.741

9.  Distinct Effects of Inorganic Phosphate on Cell Cycle and Apoptosis in Human Vascular Smooth Muscle Cells.

Authors:  Haifa Rahabi-Layachi; Roger Ourouda; Agnes Boullier; Ziad A Massy; Carole Amant
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

10.  Intense light-elicited upregulation of miR-21 facilitates glycolysis and cardioprotection through Per2-dependent mechanisms.

Authors:  Colleen Marie Bartman; Yoshimasa Oyama; Kelley Brodsky; Ludmila Khailova; Lori Walker; Michael Koeppen; Tobias Eckle
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

View more
  3 in total

Review 1.  A new perspective on the function of Tissue Non-Specific Alkaline Phosphatase: from bone mineralization to intra-cellular lipid accumulation.

Authors:  Cara-Lesley Bartlett; Eleanor Margaret Cave; Nigel John Crowther; William Frank Ferris
Journal:  Mol Cell Biochem       Date:  2022-04-26       Impact factor: 3.396

Review 2.  Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease.

Authors:  Merita Rroji; Andreja Figurek; Davide Viggiano; Giovambattista Capasso; Goce Spasovski
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

3.  Phosphate and Cellular Senescence.

Authors:  Ming Chang Hu; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.